Literature DB >> 24701361

Abdominal aortic aneurysms and coronary artery disease in a small country with high cardiovascular burden.

Hassan Al-Thani1, Ayman El-Menyar2.   

Abstract

We aimed to evaluate the frequency, clinical profiles and outcomes of abdominal aortic aneurysms (AAA), and their association with coronary artery disease (CAD) in a small country with high cardiovascular burden. Methods. Data were collected for all adult patients who underwent abdominal computed tomography scans at Hamad General Hospital in Qatar between 2004 and 2008. Results. Out of 13,115 screened patients for various reasons, 61 patients (0.5%) had abdominal aneurysms. The majority of AAA patients were male (82%) with a mean age of 67 ± 12 years. The incidence of AAA substantially increased with age reaching up to 5% in patients >80 yrs. Hypertension was the most prevalent risk factor for AAA followed by smoking, dyslipidemia, renal impairment, and diabetes mellitus. CAD and peripheral arterial disease (PAD) were observed in 36% and 13% of AAA patients, respectively. There were no significant correlations between CAD or PAD and site and size of AAA. Conclusion. This is the largest study in our region that describes the epidemiology of AAA with concomitant CAD. As the mortality rate is quite high in this high risk population, routine screening for AAA in CAD patients and vice versa needs further studies for proper risk stratification.

Entities:  

Year:  2014        PMID: 24701361      PMCID: PMC3950591          DOI: 10.1155/2014/825461

Source DB:  PubMed          Journal:  ISRN Cardiol        ISSN: 2090-5580


1. Introduction

Screening programs for abdominal aortic aneurysm (AAA) are lacking in the developing countries. Global data reported that the prevalence of AAA varies in men (1.3%–8.9%) and women (11%–2.2%) [1]. The rising incidence of AAA is related mainly to the increase in age, physician awareness with clinical high index of suspicion, and the use of advanced diagnostic modalities. As AAA is a silent process, it may present only with aneurysmal rupture in most of cases. It was believed for a long time that atherosclerosis is the main pathogenesis of AAA. However, this speculation has raised a question that whether atherosclerosis is a “bystander” condition or an active factor for the initiation or acceleration of AAA [1, 2]. In a systematic review, Elkalioubie et al. evaluated 17 published studies between 1991 and 2010 [1]. The authors found that the frequency of AAA among coronary artery disease patients ranged between 0.48% and 18.2% [1]. As advanced age is a potential risk factor for both coronary artery disease and AAA, five studies specifically recruited patients who were above 60 years. Salem et al. [3] reported a lower prevalence of AAA among men of Asian origin (China and Iran), indicating that certain ethnic groups experience a disproportionately smaller burden of AAA. Notably, the prevalence of AAA in coronary artery disease patients was comparable to that reported in AAA screening studies among patients with different vascular bed affection such as peripheral vascular disease (PAD) (7%–17%) and cerebrovascular disease (8.4%–20.2%) [1, 4, 5]. Herein, we aim to evaluate the frequency, clinical profiles and outcomes of AAA, and its coronary artery disease association in Qatar. Qatar is a small rapidly developing country in the Middle East that is characterized with high prevalence of cardiovascular risk burden [6, 7].

2. Methods

Data were collected from March 2004 to March 2008 for all adult patients who underwent abdominal computed tomography scans at Hamad General Hospital in Qatar. All adult patients who underwent abdominal CT scans for any reason were included in the study and those with diagnosed abdominal aneurysms were followed up for 3 years for major events (AAA rupture and mortality). AAA was defined as an abnormal dilatation of the abdominal aorta with a maximal diameter of ≥3 cm. CAD was defined as history of documented coronary events, history of percutaneous or surgical coronary intervention or currently on anti-ischemic medications. PAD was defined as intermittent claudication, vascular lab diagnosis, or lower-limb arterial revascularization [7]. Data were reported in percentage, mean ± SD, and median and range, when applicable. Data analysis was carried out using the Statistical Package for Social Sciences version 18 (SPSS Inc. USA).

3. Results

Out of  13,115 screened patients for various reasons, 61 patients (0.5%) were identified to have abdominal aneurysms. The majority of AAA patients were male (82%) with a mean age of 67 ± 12 years (Table 1). The incidence of AAA substantially increased with age reaching up to 5% in elderly patients (>80 years). The main location of AAA was infrarenal (67%), followed by thoracoabdominal (23%). The mean AAA diameter was 5.3 ± 2.5 cm with a range from 3 to 14 cm. AAA of diameter ≥5.5 and ≥7 cm comprised 41% and 26% of cases, respectively. Figure 1 shows the AAA in different age groups.
Table 1

Clinical presentation and outcome of AAA.

Number of patients %
Total AA610.5%
Age, median    69 (26–88)
Age ≥ 65 yrs4167%
Infrarenal AAA4167
Thoracoabdominal 1423
AAA rupture 58
Died 1633
Male 5082
Diabetics 2541
Hypertension 4066
Dyslipidemia 3151
Smoking 3760%
Coronary artery disease2236
Size of AAAMean 5.3 ± 2.5, median 4.8 (3–14)
Size ≥ 5.5 cm2241%
Size ≥ 7 cm1426%
Figure 1

Abdominal aortic aneurysm in different age groups.

The rate of AAA rupture was 8%, with an overall mortality of 33%. Among ruptured AAA, all patients were above 60 years old; 80% had AAA diameter of ≥5.5 cm and 60% of them died. Moreover, 80% of AAA located infrarenally. Cardiovascular risk factors were prevalent among AAA patients in terms of hypertension (66%), smoking (60%), dyslipidemia (51%), renal impairment (46%), and diabetes mellitus (41%). CAD was prevalent in more than one-third of cases (36%), whereas PAD was observed in 13% of AAA patients. There were no significant correlations between CAD or PAD and site and size of AAA. Figure 2 shows the rates of AAA rupture and deaths in different AAA size groups.
Figure 2

Rates of AAA rupture and deaths in different AAA size groups.

Table 2 shows the clinical profile of patients with AAA who had concomitant CAD. Patients with coexistent CAD were older (median age of 72 years); 91% of them were males and had high prevalence of cardiovascular risk factors as hypertension (86%), dyslipidemia (82%), and diabetes mellitus (54.5%). The mortality rate was 47% in patients with combined AAA and CAD, while AAA patients without CAD had 26% mortality rate.
Table 2

AAA with history of coronary artery disease.

Age in yrs, median (range)72 (44–82)
Male gender %91
Diabetes mellitus %54.5
Hypertension %86.5
Dyslipidemia %82
Peripheral arterial disease %23
Age ≥ 60 yrs91%
AAA location
 Infrarenal 68%
 Thoracoabdominal18%
AAA size (cm)
 ≥5.530%
 ≥720%
 Ruptured AAA4.5%
 Died 47%

4. Discussion

This is the largest study that describes the frequency of incidental AAA and concomitant CAD in the Arab Gulf Region. In our data, incidental abdominal aneurysms were detected in 0.5% of screened patients, of which the majority (67%) was ≥65 years old. The cardiovascular risk factors were prevalent among AAA patients in our study. Two-thirds of AAA patients were hypertensive, 60% were smokers, about half had dyslipidemia, and 41% had diabetes mellitus. History of CAD and PAD was observed in 36% and 13% of AAA patients, respectively. Among CAD patients, atherosclerosis risk factors such as age, smoking, and existence of other vascular bed affection showed an association with AAA [1]. This association addresses the need for screening for AAA in high risk population. Our analysis showed that the mortality was almost 2-fold greater in AAA patients if the history of CAD is present. Table 3 summarizes the factors associated with increased risk of developing AAA and the recommendations for routine screening for AAA [8, 9].
Table 3

Factors associated with increased risk of developing an AAA.

Old age
Gender
 Men develop AAA 4-5 times more often than women
Ethnicity
 White people develop AAA more frequently than other ethnicities
Vascular bed affection
 People with CAD and PAD are more likely to develop AAA than those who are otherwise healthy
Family history
 A family history of AAA increases the risk of developing AAA
 The risk of developing an AAA among brothers of a patient with a known AAA who are >60 years old is as high as 18%
Cardiovascular risk factors
 (i) Smoking: the risk is directly related to number of years smoking
 (ii) Diabetes mellitus: there is a negative association with diabetes mellitus and AAA
 (iii) Hypertension is a poor predictor for AAA development but important risk factor for expansion and rupture
 (iv) Lipid: there is no and weak correlation between risk for AAA and high serum triglyceride and cholesterol, respectively
Recommendations for AAA screening
 Men of age 65–75 who have ever smoked should be screened one time for AAA with abdominal ultrasound
 Men > 75 are unlikely to benefit from screening
 Men age ≥ 60 who have a sibling or parent with an AAA should have a physical examination and abdominal ultrasound
 There is no recommendation for general screening for AAA in women
  (i) Women who have an increased risk for AAA (those who smoke have a family history of -AAA, or other risk factors) should be put into consideration
  (ii) The risk of rupture in women is higher than in men, and so some data are in favor of one-time screening for women with risk factors
It has been shown that not all patients with atherosclerotic disease develop an AAA. Few studies reported that many AAA patients lack concomitant atherosclerotic arterial disease [1]. Moreover, previous data did not correlate the existence or severity of each disease in the presence of the other one. Interestingly, this doubtful association presents in spite of the fact that AAA and atherosclerosis have several risk factors in common, such as male gender, increased age, smoking, and hypertension [10]. Some investigators believe that it would be useful to assess the relationship between the extent of coronary lesion and infrarenal aortic diameter and/or risk of AAA rupture [1]. On the other hand, some population-based studies showed that AAA is independently associated with preexisting CAD [11]. However, the high incidence of CAD among AAA patients was reported with an impact on the short-term survival post-AAA repair [12]. Studies that evaluated the coronary artery status prior to aortic surgery found a concomitant CAD prevalence from 31% to 90% [1, 11–13]. The retrospective nature of the current study is a considerable limitation. The breakdown and severity of CAD based on coronary angiographic features are lacking.

5. Conclusion

This is the largest study in our region that describes the epidemiology of abdominal aneurysm with concomitant CAD. The high prevalence of CAD does not express site, size, or severity of AAA so far. As the mortality rate is quite high in this high risk population, routine screening for AAA in CAD patients and vice versa needs further studies for proper risk stratification.
  12 in total

1.  Screening for abdominal aortic aneurysm: recommendation statement.

Authors: 
Journal:  Ann Intern Med       Date:  2005-02-01       Impact factor: 25.391

2.  Should Asian men be included in abdominal aortic aneurysm screening programmes?

Authors:  M K Salem; H S Rayt; G Hussey; S Rafelt; C P Nelson; R D Sayers; A R Naylor; A Nasim
Journal:  Eur J Vasc Endovasc Surg       Date:  2009-08-08       Impact factor: 7.069

Review 3.  Abdominal aortic aneurysm repair during cardiopulmonary bypass: rationale for a combined approach.

Authors:  V Falk; T Walther; F W Mohr
Journal:  Cardiovasc Surg       Date:  1997-06

Review 4.  Angiopoietins, abdominal aortic aneurysm and atherosclerosis.

Authors:  Alexandra F Trollope; Jonathan Golledge
Journal:  Atherosclerosis       Date:  2010-08-19       Impact factor: 5.162

5.  Prevalence and impact of cardiovascular risk factors among patients presenting with acute coronary syndrome in the middle East.

Authors:  Ayman El-Menyar; Mohammad Zubaid; Abdullah Shehab; Bassam Bulbanat; Nizar Albustani; Fahad Alenezi; Ahmed Al-Motarreb; Rajvir Singh; Nidal Asaad; Jassim Al Suwaidi
Journal:  Clin Cardiol       Date:  2011-01       Impact factor: 2.882

6.  Analysis of risk factors for abdominal aortic aneurysm in a cohort of more than 3 million individuals.

Authors:  K Craig Kent; Robert M Zwolak; Natalia N Egorova; Thomas S Riles; Andrew Manganaro; Alan J Moskowitz; Annetine C Gelijns; Giampaolo Greco
Journal:  J Vasc Surg       Date:  2010-07-13       Impact factor: 4.268

Review 7.  Coronary artery disease in patients with abdominal aortic aneurysm: a review article.

Authors:  J P Van Kuijk; W J Flu; M Dunckelgrun; J J Bax; D Poldermans
Journal:  J Cardiovasc Surg (Torino)       Date:  2009-02       Impact factor: 1.888

8.  Risk factors for abdominal aortic aneurysms: a 7-year prospective study: the Tromsø Study, 1994-2001.

Authors:  Signe Helene Forsdahl; Kulbir Singh; Steinar Solberg; Bjarne K Jacobsen
Journal:  Circulation       Date:  2009-04-13       Impact factor: 29.690

9.  Prevalence of coronary artery disease, lower extremity peripheral arterial disease, and cerebrovascular disease in 110 men with an abdominal aortic aneurysm.

Authors:  Rishi Sukhija; Wilbert S Aronow; Kiran Yalamanchili; Neeraj Sinha; Sateesh Babu
Journal:  Am J Cardiol       Date:  2004-11-15       Impact factor: 2.778

10.  Prevalence of risk factors, coronary and systemic atherosclerosis in abdominal aortic aneurysm: comparison with high cardiovascular risk population.

Authors:  Alberto Palazzuoli; Palazzuoli Alberto; Maddalena Gallotta; Gallotta Maddalena; Giuseppe Guerrieri; Guerrieri Giuseppe; Ilaria Quatrini; Quatrini Ilaria; Beatrice Franci; Maria Stella Campagna; Eugenio Neri; Neri Eugenio; Antonio Benvenuti; Benvenuti Antonio; Carlo Sassi; Sassi Carlo; Ranuccio Nuti; Nuti Ranuccio
Journal:  Vasc Health Risk Manag       Date:  2008
View more
  1 in total

1.  Abdominal aorta measurements by a handheld ultrasound device compared with a conventional cart-based ultrasound machine.

Authors:  Abdulrahman M Alfuraih; Abdulaziz I Alrashed; Saleh O Almazyad; Mohammed J Alsaadi
Journal:  Ann Saudi Med       Date:  2021-12-02       Impact factor: 1.526

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.